Skip to content

IPHA

Innate Pharma SA

NASDAQ · Healthcare · Biotechnology · FR

$1.43
+7.14%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
2.11x
P/S forward
28.19x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-3.51x
Price / sales
131.22x
Price / cash flow
-3.18x

Enterprise value

Enterprise value
$169.6M
EV / sales
139.81x
EV / EBITDA
-2.92x
EV / EBIT
-3.04x
Market cap
$159.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026